613 HER2-XPAT, a novel protease-activatable prodrug T cell engager (TCE), with potent T-cell activation and efficacy in solid tumors and large predicted safety margins in non-human primate (NHP)

• Fiore Cattaruzza,
• Ayesha Nazeer,
• Zachary Lange,
• Caitlin Koski,
• Mikhail Hammond,
• Trang Dao-Pick,
• Angela Henkensiefken,
• Mika Derynck,
• Volker Schellenberger,
• Bryan Irving

Affiliations

Fiore Cattaruzza

Amunix, San Francisco, CA, USA

Ayesha Nazeer

Amunix, San Francisco, CA, USA

Zachary Lange

Amunix, San Francisco, CA, USA

Caitlin Koski

Amunix, San Francisco, CA, USA

Mikhail Hammond

Amunix, San Francisco, CA, USA

Trang Dao-Pick

Amunix, San Francisco, CA, USA

Angela Henkensiefken

Amunix, San Francisco, CA, USA

Mika Derynck

Amunix, San Francisco, CA, USA

Volker Schellenberger

Amunix, San Francisco, CA, USA

Bryan Irving

Amunix, San Francisco, CA, USA